Valley National Advisers Inc Horizon Therapeutics Public LTD CO Transaction History

Valley National Advisers Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 12, 2023	BUY	$62.39 - $113.8 $13,912 - $25,377	223 Added 40.33%	776 $87,000
Q3 2022 Nov 08, 2022	SELL	$58.92 - $84.67 $14,612 - $20,998	-248 Reduced 30.96%	553 $35,000
Q1 2022 May 06, 2022	BUY	$86.42 - $109.81 $12,098 - $15,373	140 Added 21.18%	801 $84,000
Q3 2021 Nov 10, 2021	BUY	$91.91 - $110.37 $27,848 - $33,442	303 Added 84.64%	661 $72,000
Q1 2021 May 07, 2021	BUY	$71.83 - $95.48 $4,525 - $6,015	63 Added 21.36%	358 $33,000
Q3 2020 Nov 13, 2020	BUY	$55.23 - $79.93 $16,292 - $23,579	295 New	295 $22,000

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Valley National Advisers Inc, based on Form 13F filings with the SEC.

Stay updated on Valley National Advisers Inc with notifications on news.